Structural analogues of 5-OMe-BPAT:: Synthesis and interactions with dopamine D2, D3, and serotonin 5-HT1A receptors

被引:5
|
作者
Homan, EJ
Kroodsma, E
Copinga, S
Unelius, L
Mohell, N
Wikström, HV
Grol, CJ
机构
[1] Univ Groningen, Ctr Pharm, Dept Med Chem, NL-9713 AW Groningen, Netherlands
[2] Astra Arcus AB, CNS Preclin R&D, S-15185 Sodertalje, Sweden
关键词
dopamine; serotonin; 2-aminotetralin; structure-affinity relationships;
D O I
10.1016/S0968-0896(99)00039-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Several structural analogues of 5-methoxy-2-[N-(2-benzamidoethyl)-N-n-propylamino]tetralin (5-OMe-BPAT, 1), a representative of a series of 2-aminotetralin-derived benzamides with po ten tial atypical antipsychotic properties, were synthesized and evaluated for their ability to bind to dopamine D-2A, D-3, and serotonin 5-HT1A receptors in vitro. The structure-affinity relationships revealed that the aromatic ring of the benzamide moiety of 1 contributes to the high affinities for all three receptor subtypes. Furthermore, 1 may interact with the dopamine D-2 and D-3 receptors through hydrogen bond formation with its carbonyl group. Investigation of the role of the amide hydrogen atom by amide N-alkylation was not conclusive, since conformational aspects may be responsible for the decreased dopaminergic affinities of the N'-alkylated analogues of 1. The effects of the amide modifications on the serotonin 5-HT1A receptor affinity were less pronounced, suggesting that the benzamidoethyl side-chain of 1 as a whole enhances the affinity for this receptor subtype probably through hydrophobic interactions with an accessory binding site. The structural requirements for the substituents at the basic nitrogen atom supported the hypothesis that the 2-aminotetralin moieties of the 2-aminotetralin-derived substituted benzamides may share the same binding sites as the 2-(N, N-di-n-propylamino)tetralins. (C) 1999 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1111 / 1121
页数:11
相关论文
共 50 条
  • [1] C5-substituted derivatives of 5-OMe-BPAT:: Synthesis and interactions with dopamine D2 and serotonin 5-HT1A receptors
    Homan, EJ
    Tulp, MTM
    Nilsson, JE
    Wikström, HV
    Grol, CJ
    BIOORGANIC & MEDICINAL CHEMISTRY, 1999, 7 (11) : 2541 - 2548
  • [2] Molecular modeling of the dopamine D2 and serotonin 5-HT1A receptor binding modes of the enantiomers of 5-OMe-BPAT
    Homan, EJ
    Wikström, HV
    Grol, CJ
    BIOORGANIC & MEDICINAL CHEMISTRY, 1999, 7 (09) : 1805 - 1820
  • [3] Actions of roxindole at recombinant human dopamine D2, D3 and D4 and serotonin 5-HT1A, 5-HT1B and 5-HT1D receptors
    A. Newman-Tancredi
    D. Cussac
    V. Audinot
    M. J. Millan
    Naunyn-Schmiedeberg's Archives of Pharmacology, 1999, 359 : 447 - 453
  • [4] Dopamine D2 and serotonin 5-HT1A receptors of the brain in processing of pain
    Pertovaara, A.
    Martikainen, I. K.
    Hagelberg, N.
    Hirvonen, J.
    Scheinin, H.
    Hietala, J.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 : S113 - S113
  • [5] A positron emission tomography occupancy study of brexpiprazole at dopamine D2 and D3 and serotonin 5-HT1A and 5-HT2A receptors, and serotonin reuptake transporters in subjects with schizophrenia
    Girgis, Ragy R.
    Forbes, Andy
    Abi-Dargham, Anissa
    Slifstein, Mark
    NEUROPSYCHOPHARMACOLOGY, 2020, 45 (05) : 786 - 792
  • [6] A positron emission tomography occupancy study of brexpiprazole at dopamine D2 and D3 and serotonin 5-HT1A and 5-HT2A receptors, and serotonin reuptake transporters in subjects with schizophrenia
    Ragy R. Girgis
    Andy Forbes
    Anissa Abi-Dargham
    Mark Slifstein
    Neuropsychopharmacology, 2020, 45 : 786 - 792
  • [7] Binding of β-carbolines and related agents at serotonin (5-HT2 and 5-HT1A), dopamine (D2) and benzodiazepine receptors
    Glennon, RA
    Dukat, M
    Grella, B
    Hong, SS
    Costantino, L
    Teitler, M
    Smith, C
    Egan, C
    Davis, K
    Mattson, MV
    DRUG AND ALCOHOL DEPENDENCE, 2000, 60 (02) : 121 - 132
  • [8] Actions of roxindole at recombinant human dopamine D2, D3 and D4 and serotonim 5-HT1A, 5-HT1B and 5-HT1D receptors
    Newman-Tancredi, A
    Cussac, D
    Audinot, V
    Millan, MJ
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1999, 359 (06) : 447 - 453
  • [9] Anticonvulsant action of hippocampal dopamine and serotonin is independently mediated by D2 and 5-HT1A receptors
    Clinckers, R
    Smolders, I
    Meurs, A
    Ebinger, G
    Michotte, Y
    JOURNAL OF NEUROCHEMISTRY, 2004, 89 (04) : 834 - 843
  • [10] Targeting Dopamine D3 and Serotonin 5-HT1A and 5-HT2A Receptors for Developing Effective Antipsychotics: Synthesis, Biological Characterization, and Behavioral Studies
    Brindisi, Margherita
    Butini, Stefania
    Franceschini, Silvia
    Brogi, Simone
    Trotta, Francesco
    Ros, Sindu
    Cagnotto, Alfredo
    Salmona, Mario
    Casagni, Alice
    Andreassi, Marco
    Saponara, Simona
    Gorelli, Beatrice
    Weikop, Pia
    Mikkelsen, Jens D.
    Scheel-Kruger, Jorgen
    Sandager-Nielsen, Karin
    Novellino, Ettore
    Campiani, Giuseppe
    Gemma, Sandra
    JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (22) : 9578 - 9597